Showing results (651-660 of 5,006) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|February 8, 2006
Does breast size affect the scatter dose to the ipsilateral lung, heart, or contralateral breast in primary breast irradiation using intensity-modulated radiation therapy (IMRT)?Ajay K Bhatnagar, Dwight E Heron, Melvin Deutsch, et al.
American Journal of Clinical Oncology|August 1, 1991
Limited small-cell lung cancer: do favorable short-term results predict ultimate outcome?J Armstrong, B Shank, H Scher, et al.
American Journal of Clinical Oncology|August 1, 1991
Phase II trial of mitoxantrone in head and neck carcinomaK S Sridhar, A M Hussein, P Benedetto, et al.
American Journal of Clinical Oncology|August 1, 1991
Redevelopment of small-cell lung cancer nine years after the start of therapy. A case report and review of the literatureN Masuda, M Fukuoka, M Takada, et al.
American Journal of Clinical Oncology|April 1, 2008
There is a wide range of predictive dosimetric factors for I-125 and pd-103 prostate brachytherapyAndrew Herstein, Kent Wallner, Gregory Merrick, et al.
American Journal of Clinical Oncology|April 1, 2008
Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapyDiclehan Unsal, Nalan Akyurek, Aytug Uner, et al.
American Journal of Clinical Oncology|April 1, 2008
Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret HospitalJeff Rothenstein, Sean P Cleary, Gregory R Pond, et al.
American Journal of Clinical Oncology|April 1, 2008
High DcR3 expression predicts stage pN2-3 in gastric cancerYulian Wu, Enqi Guo, Junxiu Yu, et al.
American Journal of Clinical Oncology|April 9, 2008
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapyM Reni, S Cereda, E Mazza, et al.
American Journal of Clinical Oncology|April 9, 2008
Autologous large multivalent immunogen vaccine in patients with metastatic melanoma and renal cell carcinomaArkadiusz Z Dudek, Matthew F Mescher, Ian Okazaki, et al.
Pageof 501